The DOI matches its Crossref record; 277 of the 277 references it cites were found in a registry or an index.
Are amyloid diseases caused by protein aggregates that mimic bacterial pore-forming toxins?
Open accessAbstract
1. Introduction 2 2. What is the significance of the shared structural properties of disease-associated protein fibrils? 3 2.1 Mechanism of amyloid fibril formation in vitro 6 2.1.1 In vitro fibril formation involves transient population of ordered aggregates of intermediate stability, or protofibrils 6 3. Toxic properties of protofibrils 7 3.1 Protofibrils, rather than fibrils, are likely to be pathogenic 7 3.2 The toxic protofibril may be a mixture of related species 8 3.3 Morphological similarities of protofibrils suggest a common mechanism of toxicity 9 3.4 Are the amyloid diseases a subset of a much larger class of previously unrecognized protofibril diseases? 9 3.5 Fibrils, in the form of aggresomes, may function to sequester toxic protofibrils 9 4. Amyloid pores, a common structural link among protein aggregation neurodegenerative diseases 10 4.1 Mechanistic studies of amyloid fibril formation reveal common features, including pore-like protofibrils 10 4.1.1 Amyloid-β (Aβ) (Alzheimer's disease) 10 4.1.2 α-Synuclein (PD and diffuse Lewy body disease) 12 4.1.3 ABri (familial British dementia) 13 4.1.4 Superoxide dismutase-1 (amyotrophic lateral sclerosis) 13 4.1.5 Prion protein (Creutzfeldt–Jakob disease, bovine spongiform encephalopathy, etc.) 14 4.1.6 Huntingtin (Huntington's disease) 14 4.2 Amyloidogenic proteins that are not linked to disease also from pore-like protofibrils 15 4.3 Amyloid proteins form non-fibrillar aggregates that have properties of protein channels or pores 15 4.3.1 Aβ ‘channels’ 15 4.3.2 α-Synuclein ‘pores’ 16 4.3.3 PrP ‘channels’ 16 4.3.4 Polyglutamine ‘channels’ 17 4.4 Nature uses β-strand-mediated protein oligomerization to construct pore-forming toxins 17 5. Mechanisms of protofibril induced toxicity in protein aggregation diseases 19 5.1 The amyloid pore can explain the age-association and cell-type selectivity of the neurodegenerative diseases 19 5.2 Protofibrils may promote their own accumulation by inhibiting the proteasome 20 6. Testing the amyloid pore hypothesis by attempting to disprove it 21 7. Acknowledgments 22 8. References 22 Protein fibrillization is implicated in the pathogenesis of most, if not all, age-associated neurodegenerative diseases, but the mechanism(s) by which it triggers neuronal death is unknown. Reductionist in vitro studies suggest that the amyloid protofibril may be the toxic species and that it may amplify itself by inhibiting proteasome-dependent protein degradation. Although its pathogenic target has not been identified, the properties of the protofibril suggest that neurons could be killed by unregulated membrane permeabilization, possibly by a type of protofibril referred to here as the ‘amyloid pore’. The purpose of this review is to summarize the existing supportive circumstantial evidence and to stimulate further studies designed to test the validity of this hypothesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
Alzheimer's disease: the amyloid cascade hypothesis
Hardy, J. A., & Higgins, G. A. (1992) · Science · doi:10.1126/science.1566067 · Cited by 7,484
Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., et al. (1993) · Nature · doi:10.1038/362059a0 · Cited by 7,062
Dauer, W., & Przedborski, S. (2003) · Neuron · doi:10.1016/s0896-6273(03)00568-3 · Cited by 5,469
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227
Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397
α-Synuclein Locus Triplication Causes Parkinson's Disease
Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., et al. (2003) · Science · doi:10.1126/science.1090278 · Cited by 4,383
Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291
Cited by
The proteostasis network and its decline in ageing
Hipp, M. S., Kasturi, P., & Hartl, F. U. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-019-0101-y · Cited by 1,642
Function and structure of inherently disordered proteins
Dunker, A. K., Silman, I., Uversky, V. N., & Sussman, J. L. (2008) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2008.10.002 · Cited by 963
Different Species of α-Synuclein Oligomers Induce Calcium Influx and Seeding
Danzer, K. M., Haasen, D., Karow, A. R., Moussaud, S., Habeck, M., Giese, A., Kretzschmar, H., Hengerer, B., & Kostka, M. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2617-07.2007 · Cited by 765
A century-old debate on protein aggregation and neurodegeneration enters the clinic
Lansbury, P. T., & Lashuel, H. A. (2006) · Nature · doi:10.1038/nature05290 · Cited by 687
Self-citationAmyloidogenic Protein–Membrane Interactions: Mechanistic Insight from Model Systems
Butterfield, S. M., & Lashuel, H. A. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.200906670 · Cited by 592
Self-citation
Metadata
- Authors
- Lashuel, H. A., & Lansbury, P. T.
- Venue
- Quarterly Reviews of Biophysics
- Publisher
- Cambridge University Press (CUP)
- Published
- 2006-05
- Volume
- 39
- Issue
- 2
- Pages
- 167-201
- ISSN
- 0033-5835 (ISSN-L)
- 1469-8994
- OpenAlex
- W2129583700
- Cited by
- 400
- References
- 277
- FWCI
- 17.06
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Are amyloid diseases caused by protein aggregates that mimic bacterial pore-forming toxins? https://app.cochat.ai/papers/10.1017/s0033583506004422
- The paper
- Lashuel, H. A., & Lansbury, P. T. (2006). Are amyloid diseases caused by protein aggregates that mimic bacterial pore-forming toxins? Quarterly Reviews of Biophysics. https://doi.org/10.1017/s0033583506004422
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.